Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study

被引:46
作者
Torres, Tiago [1 ]
Balato, Anna [2 ]
Conrad, Curdin [3 ,4 ]
Conti, Andrea [5 ]
Dapavo, Paolo [6 ]
Ferreira, Paulo [7 ]
Gaiani, Francesca [8 ]
Leite, Luiz [9 ]
Malagoli, Piergiorgio [8 ]
Mendes-Bastos, Pedro [7 ]
Megna, Matteo [2 ]
Messina, Francesco [10 ]
Nidegger, Alessia [3 ,4 ]
Odorici, Giulia [5 ]
Piaserico, Stefano [13 ]
Prignano, Francesca [11 ]
Ribero, Simone [6 ]
Ricceri, Federica [11 ]
Tonini, Annalisa [12 ]
Valerio, Joana [9 ]
Chiricozzi, Andrea [13 ]
机构
[1] Ctr Hosp Univ Porto, Dept Dermatol, Porto, Portugal
[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[3] CHU Vaudois, Lausanne Univ Hosp, Dept Dermatol, Lausanne, Switzerland
[4] Univ Lausanne, Lausanne, Switzerland
[5] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy
[6] Univ Turin, Dermatol Clin 2, Dept Biomed Sci & Human Oncol, Turin, Italy
[7] CUF Descobertas Hosp, Lisbon, Portugal
[8] Azienda Osped San Donato Milanese, Dermatol Unit, Milan, Italy
[9] Clin Med Belem, Lisbon, Portugal
[10] Univ Padua, Dept Dermatol, Padua, Italy
[11] Univ Florence, Dept Dermatol, Florence, Italy
[12] Univ Pisa, Dept Dermatol, Pisa, Italy
[13] Catholic Univ, Fdn Policlin Univ A Gemelli IRCCS, Inst Dermatol, Rome, Italy
关键词
PLAQUE PSORIASIS;
D O I
10.1016/j.jaad.2019.02.031
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:273 / 275
页数:3
相关论文
共 5 条
  • [1] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T. N.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 509 - 519
  • [2] Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
    Georgakopoulos, Jorge R.
    Ighani, Arvin
    Phung, Michelle
    Yeung, Jensen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 1019 - 1020
  • [3] Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
    Langley, Richard G.
    Elewski, Boni E.
    Lebwohl, Mark
    Reich, Kristian
    Griffiths, Christopher E. M.
    Papp, Kim
    Puig, Lluis
    Nakagawa, Hidemi
    Spelman, Lynda
    Sigurgeirsson, Bardur
    Rivas, Enrique
    Tsai, Tsen-Fang
    Wasel, Norman
    Tyring, Stephen
    Salko, Thomas
    Hampele, Isabelle
    Notter, Marianne
    Karpov, Alexander
    Helou, Silvia
    Papavassilis, Charis
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) : 326 - 338
  • [4] Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain
    Notario, Jaime
    Deza, Gustavo
    Vilarrasa, Eva
    Valenti, Francesc
    Munoz, Carlos
    Mollet, Jordi
    Rocamora, Vicenc
    Carrascosa, Jose-Manuel
    del Alcazar, Elena
    Alsina, Merce
    Vidal, David
    Puig, Lluis
    Lopez-Ferrer, Anna
    Riera, Jose
    Gallardo, Fernando
    Ferran, Marta
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (05) : 424 - 429
  • [5] Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
    van den Reek, Juul M. P. A.
    van Vugt, Lieke J.
    van Doorn, Martijn B. A.
    van der Kraaij, Gayle E.
    de Kort, Wim J. A.
    Lucker, Georges P. H.
    Horvath, Barbara
    Njoo, M. David
    Bovenschen, H. Jorn
    Ossenkoppele, Paul M.
    De Bruin-Weller, Marjolein S.
    de Groot, Marjan
    Mommers, Roland
    Prevoo, Ruud L. M. A.
    van de Kerkhof, Peter C. M.
    Spuls, Phyllis I.
    Kievit, Wietske
    de Jong, Elke M. G. J.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2018, 98 (07) : 648 - 654